ADB sets up $9bn vaccine fund bangkokpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bangkokpost.com Daily Mail and Mail on Sunday newspapers.
News Release | 11 December 2020
MANILA, PHILIPPINES (11 December 2020) The Asian Development Bank (ADB) has launched a $9 billion vaccine initiative the Asia Pacific Vaccine Access Facility (APVAX) offering rapid and equitable support to its developing members as they procure and deliver effective and safe coronavirus disease (COVID-19) vaccines.
“As ADB’s developing members prepare to vaccinate their people as soon as possible, they need financing to procure vaccines as well as appropriate plans and knowledge to be able to safely, equitably, and efficiently manage the vaccination process,” said ADB President Masatsugu Asakawa. “APVAX will play a critical role in helping our developing members meet these challenges, overcome the pandemic, and focus on economic recovery.”
ADB launches 9-bln-USD facility to help access, distribute COVID-19 vaccines - Xinhua xinhuanet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from xinhuanet.com Daily Mail and Mail on Sunday newspapers.
Global infections: 69,619,992
Change Over Yesterday: 663,876
Global deaths: 1,582,342
Nations with most cases: US (15,616,381), India (9,796,769), Brazil (6,781,799), Russia (2,546,113), France(2,391,643).
Source:
Sanofi-GSK vaccine rollout delayed by poor results for elderly Pharma groups Sanofi and GlaxoSmithKline have said the rollout of their vaccine against Covid-19 will be delayed at least until the last quarter of 2021 because the initial version failed to produce a strong immune response in the elderly. They said that they planned to conduct further studies with an improved antigen formulation, and that the product was now expected to be available in the fourth quarter of next year provided the development plan was completed successfully. Both companies said they were disappointed by the results of the early trials of the vaccine.